
Results
2
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
2 companies
NNIT
Market Cap: DKK 1.0b
Provides information technology solutions for life sciences, public, and private sectors in Denmark, Europe, the United States, and Asia.
NNIT
DKK 40.75
7D
0.4%
1Y
-41.8%
Gubra
Market Cap: DKK 5.6b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 340.00
7D
3.3%
1Y
-15.8%